Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 2Brain Neoplasms 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Observational × Perfusion Magnetic Resonance Imaging × Clear all
NCT04143425 2024-05-14

Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma

Asan Medical Center

Completed
15 enrolled
CNS

Glioblastoma

NCT02843230 2022-04-08

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Massachusetts General Hospital

Completed
30 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡